FDA 483 - Baxter Healthcare Corporation - November 25, 2025

The FDA inspected Baxter Healthcare Corporation in Round Lake, IL, a contract laboratory, and issued a Form 483 with five observations. The inspection revealed significant deficiencies in laboratory controls, quality control unit oversight, computer system controls, personnel training, and laboratory record-keeping. These issues primarily concern environmental monitoring, cross-contamination risks, and data integrity for drug products.